BIO-RAD LABORATORIES -CL B (BIO.B) Stock Analyst Ratings
NYSE:BIO.B - New York Stock Exchange, Inc. - US0905721082 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to BIO.B. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 357.4. This target is 34.45% above the current price.
BIO.B was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about BIO.B.
In the previous month the buy percentage consensus was at a similar level.
BIO.B was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-07-30 | Wells Fargo | Maintains | Overweight |
| 2021-02-12 | Citigroup | Maintains | Buy |